Development of an autonomous solvent extraction system to isolate astatine-211 from dissolved cyclotron bombarded bismuth targets

Cyclotron-produced astatine-211 ((211)At) shows tremendous promise in targeted alpha therapy (TAT) applications due to its attractive half-life and its 100% α-emission from nearly simultaneous branched alpha decay. Astatine-211 is produced by alpha beam bombardment of naturally monoisotopic bismuth...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Hara, Matthew J., Krzysko, Anthony J., Hamlin, Donald K., Li, Yawen, Dorman, Eric F., Wilbur, D. Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937302/
https://www.ncbi.nlm.nih.gov/pubmed/31889075
http://dx.doi.org/10.1038/s41598-019-56272-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6937302/
https://www.ncbi.nlm.nih.gov/pubmed/31889075
http://dx.doi.org/10.1038/s41598-019-56272-7

Ejemplares similares